X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (4) 4
cancer (2) 2
chemotherapy (2) 2
colon-cancer (2) 2
index medicus (2) 2
metastases (2) 2
open-label (2) 2
oxaliplatin (2) 2
prognosis (2) 2
1st-line treatment (1) 1
5-fluorouracil (1) 1
adipose-tissue (1) 1
adjuvant gemcitabine (1) 1
aged (1) 1
analysis (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic agents - pharmacology (1) 1
association (1) 1
bevacizumab (1) 1
biliary tract (1) 1
body composition (1) 1
body composition - drug effects (1) 1
body weight - drug effects (1) 1
braf inhibitors (1) 1
braf mutation (1) 1
cachexia (1) 1
calibration (1) 1
care and treatment (1) 1
cell infiltration (1) 1
chemotherapy toxicity (1) 1
cholangiocarcinoma (1) 1
cisplatin (1) 1
clinical trials (1) 1
colorectal cancer (1) 1
colorectal carcinoma (1) 1
colorectal neoplasms - drug therapy (1) 1
combination (1) 1
computed-tomography (1) 1
decision analysis (1) 1
diagnosis tripod (1) 1
doxorubicin (1) 1
drug therapy (1) 1
epidermal growth factor (1) 1
epidermal growth factor receptors (1) 1
failure (1) 1
female (1) 1
folfoxiri plus bevacizumab (1) 1
gemcitabine (1) 1
health aspects (1) 1
humans (1) 1
immunotherapy (1) 1
independent determinant (1) 1
individual prognosis (1) 1
irinotecan (1) 1
lean body-mass (1) 1
life sciences (1) 1
male (1) 1
mathematical models (1) 1
medical prognosis (1) 1
mek inhibitors (1) 1
melanoma (1) 1
metastatic colorectal cancer (1) 1
metastatic melanoma (1) 1
microsatellite instability (1) 1
middle aged (1) 1
model (1) 1
multivariate analysis (1) 1
muscle mass depletion (1) 1
muscle, skeletal - diagnostic imaging (1) 1
muscle, skeletal - drug effects (1) 1
mutation (1) 1
nab-paclitaxel (1) 1
neoplasm metastasis - drug therapy (1) 1
neoplasms. tumors. oncology. including cancer and carcinogens (1) 1
obesity (1) 1
oncogenic braf (1) 1
overall survival (1) 1
palliative care (1) 1
palliative chemotherapy (1) 1
pancreatic cancer (1) 1
peritoneum (1) 1
personalized medicine (1) 1
pharmaceutical sciences (1) 1
phase ib (1) 1
phase-iii trial (1) 1
plus gemcitabine (1) 1
pooled analysis (1) 1
precision medicine (1) 1
predictions (1) 1
prognostic biomarker (1) 1
prospective studies (1) 1
quality-of-life (1) 1
ras mutations (1) 1
review (1) 1
secreting tumor vaccine (1) 1
stratification (1) 1
suppressor-cells (1) 1
surgery (1) 1
survival (1) 1
survival analysis (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Neuzillet, Cindy and Casadei Gardini, Andrea and Brieau, Bertrand and Vivaldi, Caterina and Smolenschi, Cristina and Brandi, Giovanni and Tougeron, David and Filippi, Roberto and Vienot, Angélique and Silvestris, Nicola and Pointet, Anne-Laure and Lonardi, Sara and Rousseau, Benoît and Scartozzi, Mario and Dahan, Laetitia and Aprile, Giuseppe and Boussaha, Tarek and Malka, David and Crusz, Shantini M and Le Sourd, Samuel and Meurisse, Aurélia and Lièvre, Astrid and Vernerey, Dewi and Evesque, Ludovic and Heurgué, Alexandra and Desramé, Jérôme and Lecomte, Thierry and Cacheux, Wulfran and Bachet, Jean-Baptiste and Phelip, Jean-Marc and Hautefeuille, Vincent and Hammoudi, Nassim and Mary, Florence and Locher, Christophe and Bidault-Thirot, Anne and Marthey, Lysiane and Touchefeu, Yann and Moulin, Valérie and Zaanan, Aziz and Taïeb, Julien and Casagrande, Mariaelena and Murgioni, Sabina and Santini, Daniele and Fornaro, Lorenzo and Montagnani, Francesco and Leone, Francesco and Faloppi, Luca and Giommoni, Elisa and Lutrino, Stefania Eufemia and Palloni, Andrea and Brunetti, Oronzo and Bergamo, Francesca and Vasile, Enrico and Malka, David and Propper, David and GICO (Italian Group of Cholangiocarcinoma) Investigators and the AGEO (Association des Gastro-Entérologues Oncologues) and Gustave Roussy Institute Cohort and Barts Cancer Institute Cohort and Gustave Roussy Inst Cohort and AGEO and Barts Canc Inst Cohort and GICO Investigators and AGEO (Association des Gastro-Entérologues Oncologues)
European Journal of Cancer, ISSN 0959-8049, 04/2019, Volume 111, pp. 94 - 106
Journal Article
Seminars in Oncology, ISSN 0093-7754, 2019, Volume 46, Issue 1, pp. 28 - 38
Pancreatic cancer is considered to be one of the most aggressive cancers. For unknown reasons, the incidence of pancreatic cancer is slowly rising and so too... 
Precision medicine | Drug therapy | Personalized medicine | Immunotherapy | Pancreatic cancer | PLUS GEMCITABINE | PALLIATIVE CARE | NAB-PACLITAXEL | SECRETING TUMOR VACCINE | ADJUVANT GEMCITABINE | OPEN-LABEL | CELL INFILTRATION | PHASE-III TRIAL | ONCOLOGY | QUALITY-OF-LIFE | SUPPRESSOR-CELLS
Journal Article
Therapeutic Advances in Medical Oncology, 06/2019, Volume 11
Over the past two decades, the molecular characterization of metastatic colorectal cancer (mCRC) has been revolutionized by the routine implementation of RAS... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2020, Volume 38, Issue 4_suppl, pp. 552 - 552
552 Background: Biliary tract cancers (BTC) are rare and heterogeneous cancers with poor prognosis. Several actionable genomic targets have been described in... 
Journal Article
6/2019, Volume 11, 15
Over the past two decades, the molecular characterization of metastatic colorectal cancer (mCRC) has been revolutionized by the routine implementation of RAS... 
colorectal cancer | chemotherapy | BRAF inhibitors | BRAF mutation | 1ST-LINE TREATMENT | PHASE IB | MICROSATELLITE INSTABILITY | OPEN-LABEL | FOLFOXIRI PLUS BEVACIZUMAB | ONCOGENIC BRAF | COLON-CANCER | METASTATIC MELANOMA | ONCOLOGY | RAS MUTATIONS | POOLED ANALYSIS
Book Review
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.